Correction: Safety and Efficacy of Biologic Therapies (Ustekinumab and Vedolizumab) in the Treatment of Inflammatory Bowel Disease (IBD): A Systematic Review
- PMID: 41000146
- PMCID: PMC12459745
- DOI: 10.7759/cureus.c318
Correction: Safety and Efficacy of Biologic Therapies (Ustekinumab and Vedolizumab) in the Treatment of Inflammatory Bowel Disease (IBD): A Systematic Review
Abstract
[This corrects the article DOI: 10.7759/cureus.48338.].
Copyright © 2025, Ashraf et al.
Conflict of interest statement
No competing interests declared.
Erratum for
-
Safety and Efficacy of Biologic Therapies (Ustekinumab and Vedolizumab) in the Treatment of Inflammatory Bowel Disease (IBD): A Systematic Review.Cureus. 2023 Nov 6;15(11):e48338. doi: 10.7759/cureus.48338. eCollection 2023 Nov. Cureus. 2023. PMID: 38060699 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources